Advanced search
Add to list

Lorcaserin safety in overweight or obese patients

Author
Organization
Keywords
CHLOROPHENYLPIPERAZINE, HEADACHE

Citation

Please use this url to cite or link to this publication:

MLA
Vandenbussche, Nicolas, and Peter J. Goadsby. “Lorcaserin Safety in Overweight or Obese Patients.” NEW ENGLAND JOURNAL OF MEDICINE, vol. 380, no. 1, 2019, pp. 99–99, doi:10.1056/nejmc1813971.
APA
Vandenbussche, N., & Goadsby, P. J. (2019). Lorcaserin safety in overweight or obese patients. NEW ENGLAND JOURNAL OF MEDICINE, 380(1), 99–99. https://doi.org/10.1056/nejmc1813971
Chicago author-date
Vandenbussche, Nicolas, and Peter J Goadsby. 2019. “Lorcaserin Safety in Overweight or Obese Patients.” NEW ENGLAND JOURNAL OF MEDICINE 380 (1): 99–99. https://doi.org/10.1056/nejmc1813971.
Chicago author-date (all authors)
Vandenbussche, Nicolas, and Peter J Goadsby. 2019. “Lorcaserin Safety in Overweight or Obese Patients.” NEW ENGLAND JOURNAL OF MEDICINE 380 (1): 99–99. doi:10.1056/nejmc1813971.
Vancouver
1.
Vandenbussche N, Goadsby PJ. Lorcaserin safety in overweight or obese patients. NEW ENGLAND JOURNAL OF MEDICINE. 2019;380(1):99–99.
IEEE
[1]
N. Vandenbussche and P. J. Goadsby, “Lorcaserin safety in overweight or obese patients,” NEW ENGLAND JOURNAL OF MEDICINE, vol. 380, no. 1, pp. 99–99, 2019.
@article{8610656,
  author       = {{Vandenbussche, Nicolas and Goadsby, Peter J}},
  issn         = {{0028-4793}},
  journal      = {{NEW ENGLAND JOURNAL OF MEDICINE}},
  keywords     = {{CHLOROPHENYLPIPERAZINE,HEADACHE}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{99--99}},
  title        = {{Lorcaserin safety in overweight or obese patients}},
  url          = {{http://dx.doi.org/10.1056/nejmc1813971}},
  volume       = {{380}},
  year         = {{2019}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: